Chapter/Section Purchase

1 Study Coverage
1.1 Quadrivalent Flu Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Quadrivalent Flu Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Intramuscular Injection
1.2.3 Nasal Spray
1.2.4 Intradermal Shot
1.3 Market by Application
1.3.1 Global Quadrivalent Flu Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Public Health Agency
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Quadrivalent Flu Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Quadrivalent Flu Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Quadrivalent Flu Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Quadrivalent Flu Vaccine Sales by Region
2.4.1 Global Quadrivalent Flu Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Quadrivalent Flu Vaccine by Region (2023-2028)
2.5 Global Quadrivalent Flu Vaccine Revenue by Region
2.5.1 Global Quadrivalent Flu Vaccine Revenue by Region (2017-2022)
2.5.2 Global Quadrivalent Flu Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Quadrivalent Flu Vaccine Sales by Manufacturers
3.1.1 Global Top Quadrivalent Flu Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Quadrivalent Flu Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Quadrivalent Flu Vaccine in 2021
3.2 Global Quadrivalent Flu Vaccine Revenue by Manufacturers
3.2.1 Global Quadrivalent Flu Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Quadrivalent Flu Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Quadrivalent Flu Vaccine Revenue in 2021
3.3 Global Quadrivalent Flu Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Quadrivalent Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Quadrivalent Flu Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Quadrivalent Flu Vaccine Sales by Type
4.1.1 Global Quadrivalent Flu Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Quadrivalent Flu Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Quadrivalent Flu Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Quadrivalent Flu Vaccine Revenue by Type
4.2.1 Global Quadrivalent Flu Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Quadrivalent Flu Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Quadrivalent Flu Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Quadrivalent Flu Vaccine Price by Type
4.3.1 Global Quadrivalent Flu Vaccine Price by Type (2017-2022)
4.3.2 Global Quadrivalent Flu Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Quadrivalent Flu Vaccine Sales by Application
5.1.1 Global Quadrivalent Flu Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Quadrivalent Flu Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Quadrivalent Flu Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Quadrivalent Flu Vaccine Revenue by Application
5.2.1 Global Quadrivalent Flu Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Quadrivalent Flu Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Quadrivalent Flu Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Quadrivalent Flu Vaccine Price by Application
5.3.1 Global Quadrivalent Flu Vaccine Price by Application (2017-2022)
5.3.2 Global Quadrivalent Flu Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Quadrivalent Flu Vaccine Market Size by Type
6.1.1 North America Quadrivalent Flu Vaccine Sales by Type (2017-2028)
6.1.2 North America Quadrivalent Flu Vaccine Revenue by Type (2017-2028)
6.2 North America Quadrivalent Flu Vaccine Market Size by Application
6.2.1 North America Quadrivalent Flu Vaccine Sales by Application (2017-2028)
6.2.2 North America Quadrivalent Flu Vaccine Revenue by Application (2017-2028)
6.3 North America Quadrivalent Flu Vaccine Market Size by Country
6.3.1 North America Quadrivalent Flu Vaccine Sales by Country (2017-2028)
6.3.2 North America Quadrivalent Flu Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Quadrivalent Flu Vaccine Market Size by Type
7.1.1 Europe Quadrivalent Flu Vaccine Sales by Type (2017-2028)
7.1.2 Europe Quadrivalent Flu Vaccine Revenue by Type (2017-2028)
7.2 Europe Quadrivalent Flu Vaccine Market Size by Application
7.2.1 Europe Quadrivalent Flu Vaccine Sales by Application (2017-2028)
7.2.2 Europe Quadrivalent Flu Vaccine Revenue by Application (2017-2028)
7.3 Europe Quadrivalent Flu Vaccine Market Size by Country
7.3.1 Europe Quadrivalent Flu Vaccine Sales by Country (2017-2028)
7.3.2 Europe Quadrivalent Flu Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Quadrivalent Flu Vaccine Market Size by Type
8.1.1 Asia Pacific Quadrivalent Flu Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Quadrivalent Flu Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Quadrivalent Flu Vaccine Market Size by Application
8.2.1 Asia Pacific Quadrivalent Flu Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Quadrivalent Flu Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Quadrivalent Flu Vaccine Market Size by Region
8.3.1 Asia Pacific Quadrivalent Flu Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Quadrivalent Flu Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Quadrivalent Flu Vaccine Market Size by Type
9.1.1 Latin America Quadrivalent Flu Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Quadrivalent Flu Vaccine Revenue by Type (2017-2028)
9.2 Latin America Quadrivalent Flu Vaccine Market Size by Application
9.2.1 Latin America Quadrivalent Flu Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Quadrivalent Flu Vaccine Revenue by Application (2017-2028)
9.3 Latin America Quadrivalent Flu Vaccine Market Size by Country
9.3.1 Latin America Quadrivalent Flu Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Quadrivalent Flu Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Quadrivalent Flu Vaccine Market Size by Type
10.1.1 Middle East and Africa Quadrivalent Flu Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Quadrivalent Flu Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Quadrivalent Flu Vaccine Market Size by Application
10.2.1 Middle East and Africa Quadrivalent Flu Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Quadrivalent Flu Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Quadrivalent Flu Vaccine Market Size by Country
10.3.1 Middle East and Africa Quadrivalent Flu Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Quadrivalent Flu Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Corporation Information
11.1.2 Sanofi Pasteur Overview
11.1.3 Sanofi Pasteur Quadrivalent Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Pasteur Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Pasteur Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Quadrivalent Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 CSL
11.3.1 CSL Corporation Information
11.3.2 CSL Overview
11.3.3 CSL Quadrivalent Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 CSL Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CSL Recent Developments
11.4 Abbott
11.4.1 Abbott Corporation Information
11.4.2 Abbott Overview
11.4.3 Abbott Quadrivalent Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Abbott Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Abbott Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Quadrivalent Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GlaxoSmithKline Quadrivalent Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Quadrivalent Flu Vaccine Industry Chain Analysis
12.2 Quadrivalent Flu Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Quadrivalent Flu Vaccine Production Mode & Process
12.4 Quadrivalent Flu Vaccine Sales and Marketing
12.4.1 Quadrivalent Flu Vaccine Sales Channels
12.4.2 Quadrivalent Flu Vaccine Distributors
12.5 Quadrivalent Flu Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Quadrivalent Flu Vaccine Industry Trends
13.2 Quadrivalent Flu Vaccine Market Drivers
13.3 Quadrivalent Flu Vaccine Market Challenges
13.4 Quadrivalent Flu Vaccine Market Restraints
14 Key Findings in The Global Quadrivalent Flu Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer